Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women

Beta-adrenergic signaling, a novel target for cancer therapy?

(2015)   Oncotarget

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

(2015)   Oncotarget

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy

(2013) H. M. Wang et al.   ANNALS OF ONCOLOGY

Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

(2013) Matteo Monami et al.   CURRENT MEDICAL RESEARCH AND OPINION

Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's Letter to the Editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of β-Blockers and Prostate Cancer–Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007

(2013) Helene Hartvedt Grytli et al.   EUROPEAN UROLOGY

Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

(2013) Gitte Vrelits Sørensen et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta blocker use and colorectal cancer risk

(2012) Lina Jansen et al.   CANCER

Impact of beta blockers on epithelial ovarian cancer survival

(2012) Elena S. Diaz et al.   GYNECOLOGIC ONCOLOGY

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy

(2012) Helene Hartvedt Grytli et al.   PROSTATE

Stimulation of Host Bone Marrow Stromal Cells by Sympathetic Nerves Promotes Breast Cancer Bone Metastasis in Mice

(2012) J. Preston Campbell et al.   PLOS BIOLOGY

Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma

(2011) Vincenzo De Giorgi et al.   ARCHIVES OF INTERNAL MEDICINE

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

(2011) Patricia A. Ganz et al.   BREAST CANCER RESEARCH AND TREATMENT

 -Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study

(2011) S. Lemeshow et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.

(2011) Steven W. Cole et al.   CLINICAL CANCER RESEARCH

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

(2011) Amal Melhem-Bertrandt et al.   JOURNAL OF CLINICAL ONCOLOGY

Using β-blockers to inhibit breast cancer progression

(2011) Desmond G. Powe et al.   Nature Reviews Clinical Oncology

Previously unsuspected widespread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action

(2011) C.J. Daly et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Beta-Blockers in Hypertension

(2010) C. Venkata S. Ram   AMERICAN JOURNAL OF CARDIOLOGY

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis

(2008) Marganit Benish et al.   ANNALS OF SURGICAL ONCOLOGY